Bacillus anthracis, a story of nature subverted by man

1 September 2005

journal article
review article
Published by Oxford University Press (OUP) in Letters in Applied Microbiology

Vol. 41 (3) , 227-229
https://doi.org/10.1111/j.1472-765x.2005.01786.x

Abstract

Bacillus anthracis is a pathogen of animals which rarely infects humans. Its use as a bioweapon has stimulated efforts to develop genetic typing methods and therapeutics to respond to an attack. Of particular concern is the transfer of virulence genes from B. anthracis to other closely related strains of bacillus.

Keywords

This publication has 28 references indexed in Scilit:

Role of superoxide in the germination ofBacillus anthracisendospores
FEMS Microbiology Letters, 2005
Human-derived, plant-produced monoclonal antibody for the treatment of anthrax
Vaccine, 2005
Characterization of the human immune response to the UK anthrax vaccine
FEMS Immunology & Medical Microbiology, 2004
DNA vaccines against anthrax
Expert Opinion on Biological Therapy, 2004
Induction of Protective Immunity against Lethal Anthrax Challenge with a Patch
The Journal of Infectious Diseases, 2004
Salmonella enterica Serovar Typhimurium Expressing a Chromosomally Integrated Copy of the Bacillus anthracis Protective Antigen Gene Protects Mice against an Anthrax Spore Challenge
Infection and Immunity, 2003
The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria
Nature, 2003
Mucosal or Parenteral Administration of Microsphere-Associated Bacillus anthracis Protective Antigen Protects against Anthrax Infection in Mice
Infection and Immunity, 2002
Delivering death in the mail
Nature, 2001
Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infection
Vaccine, 1997